NDC 55513-954 – Vectibix
Panitumumab 100 mg/5mL · Solution · Intravenous
Product NDC55513-954
Product details
- Brand name
- Vectibix
- Generic name
- Panitumumab
- Labeler
- Amgen, Inc
- Dosage form
- Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA125147
- Marketed since
- October 10, 2006
- Listing expires
- December 31, 2027
- Pharmacologic class
- Epidermal Growth Factor Receptor Antagonist
Active ingredients
- Panitumumab 100 mg/5mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 55513-954-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-954-01) / 5 mL in 1 VIAL, SINGLE-DOSE | Oct 10, 2006 |
| 55513-954-21 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-954-21) / 5 mL in 1 VIAL, SINGLE-DOSE | Oct 1, 2025 |
Other Vectibix products
- 55513-956 Panitumumab 400 mg/20mL · Solution · Amgen, Inc